Today's Date
TCZ in Pediatric New-onset T1D
(
EXTEND-P
)
ITN Protocol #:
ITN065AI
Branded Name:
EXTEND-P
Treatment Protocol #:
Therapeutic Area:
Type 1 Diabetes
Current Status:
Withdrawn
Summary:
Preserving Beta-Cell Function with Tocilizumab in Children with New-onset Type 1 Diabetes
Clinical Operations Manager
ITN Clinical Trial Physician
NIAID Project Manager
Study Personnel:
